RE:Ready to Rock?!Q3 cash 38 m....Q4 cash 34m.....medipharm has more than 2 years of operational runway at this rate....inventory write downs account for the majority of 2021 losses and management claims these write downs are concluded.....two years is along time...we may never need capital markets again I believe under Brian's leadership we can reach profitability and don't forget once the DMF is approved major supply deals will be inked...